Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 25;20(2):e0319342.
doi: 10.1371/journal.pone.0319342. eCollection 2025.

Cardiology involvement and mortality in adult patients with advanced solid cancer complicated by atrial fibrillation

Affiliations

Cardiology involvement and mortality in adult patients with advanced solid cancer complicated by atrial fibrillation

Takeshi Sato et al. PLoS One. .

Abstract

Background: The association between comorbid atrial fibrillation (AF) and survival in adult patients with advanced solid cancer, as well as the impact of cardiology involvement in such patients, remains unclear.

Methods: This retrospective cohort study included adult patients diagnosed with advanced solid cancers. We calculated prevalence of AF in different cancer types and compared all-cause mortality between patients with and without AF. We further examined the association between cardiology involvement and mortality in the subset of participants with AF.

Results: Among the 1,349 adult patients with advanced solid cancer, 122 (9.0%) had AF. The risk of AF was the highest in lung and mediastinal cancer (15.6%). AF was associated with higher all-cause mortality, which became neutral after adjustment for age, sex, comorbidities, cancer types and cancer treatments (crude hazard ratio [HR] 1.39, 95% confidence interval [CI] 1.11-1.75, p = 0.004; adjusted HR 1.08, 95%CI 0.84-1.39, p = 0.552). In those with AF, cardiology involvement was independently associated with lower all-cause mortality (age, sex, comorbidities, cancer types and cancer treatments-adjusted HR 0.50 [95%CI 0.28-0.88], p = 0.017), though the cumulative incidence of neither cardiovascular nor non-cardiovascular death differed significantly between patients who received cardiology care and those who did not.

Conclusions: In adult patients with advanced solid cancer, AF per se was not independently associated with increased mortality. Cardiology involvement in patients with advanced solid cancer and AF was linked to a better overall survival, but with low certainty that this finding is not attributable to unmeasured confounding.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. CONSORT flow diagram of patients inclusion and exclusion.
AF, atrial fibrillation; CONSORT, Consolidated Standards of Reporting Trials.
Fig 2
Fig 2. The risk of AF in adult patients with advanced solid cancer across different cancer types.
*Other cancers included gynecological cancer, thyroid cancer, oral cancer, head and neck cancer, sarcoma, and carcinoma of unknown primary. AF, atrial fibrillation.
Fig 3
Fig 3. Kaplan-Meier estimates of overall survival in adult patients with advanced solid cancer with and without AF.
Shaded zones indicate 95% confidence intervals. AF, atrial fibrillation.
Fig 4
Fig 4. Kaplan-Meier estimates of overall survival among adult patients with advanced solid cancer without AF, with AF and cardiology involvement, and with AF without cardiology involvement.
Shaded zones indicate 95% confidence intervals. * Log-rank p <  0.001. Log-rank p =  0.016. Log-rank p =  0.475. AF, atrial fibrillation.
Fig 5
Fig 5. Cumulative incidences of cardiovascular and non-cardiovascular deaths stratified by cardiology involvement among adult patients with advanced solid cancer and AF. Solid lines indicate cumulative incidences of cardiovascular deaths; and dashed lines indicate cumulative incidences of non-cardiovascular deaths. Shaded zones indicate 95% confidence intervals. AF, atrial fibrillation; CV, cardiovascular.

References

    1. Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson B, et al.. Annual report to the nation on the status of cancer, 1975-2014, featuring survival. J Natl Cancer Inst. 2017;109(9):djx030. doi: 10.1093/jnci/djx030 - DOI - PMC - PubMed
    1. Mertens AC, Liu Q, Neglia JP, Wasilewski K, Leisenring W, Armstrong GT, et al.. Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2008;100(19):1368–79. doi: 10.1093/jnci/djn310 - DOI - PMC - PubMed
    1. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al.. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498. doi: 10.1093/eurheartj/ehaa612 - DOI - PubMed
    1. Jakobsen CB, Lamberts M, Carlson N, Lock-Hansen M, Torp-Pedersen C, Gislason GH, et al.. Incidence of atrial fibrillation in different major cancer subtypes: a Nationwide population-based 12 year follow up study. BMC Cancer. 2019;19(1):1105. doi: 10.1186/s12885-019-6314-9 - DOI - PMC - PubMed
    1. Guzzetti S, Costantino G, Sada S, Fundarò C. Colorectal cancer and atrial fibrillation: a case-control study. Am J Med. 2002;112(7):587–8. doi: 10.1016/s0002-9343(02)01029-x - DOI - PubMed